Semaglutide Retatrutide Peptides Body Building 5mg / 10mg

UK Peptide Semaglutide Retatrutide 5mg/10mgDoor to Door Service

Semaglutide is a glucagon like peptide (GLP-1) receptor protein therapy drug. As an auxiliary means of diet control and exercise, it is used for adult patients with type 2 diabetes whose blood sugar level is not fully controlled to improve blood sugar control. GLP-1 agonists can delay gastric emptying and suppress appetite, with significant weight loss effects and minimal side effects. They also have effects such as lowering blood sugar and improving metabolic levels in the body.
In September 2019, the US FDA approved the marketing of Semaglutide Tablets with the trade name of RYBELSUS. The indications are: supplementary diet and exercise are used to improve the blood sugar control of adult patients with type 2 diabetes. The initial dose is 3mg, and the maintenance dose is 7mg or 14mg, once a day.